2a97

From Proteopedia

Revision as of 13:46, 20 March 2008 by OCA (Talk | contribs)
Jump to: navigation, search


PDB ID 2a97

Drag the structure with the mouse to rotate
, resolution 1.80Å
Sites: , , , , , , and
Ligands: and
Gene: botF (Clostridium botulinum)
Activity: Bontoxilysin, with EC number 3.4.24.69
Coordinates: save as pdb, mmCIF, xml



Crystal structure of catalytic domain of Clostridium botulinum neurotoxin serotype F


Overview

The seven serologically distinct Clostridium botulinum neurotoxins (BoNTs A-G) are zinc endopeptidases which block the neurotransmitter release by cleaving one of the three proteins of the soluble N-ethylmaleimide-sensitive-factor attachment protein receptor complex (SNARE complex) essential for the fusion of vesicles containing neurotransmitters with target membranes. These metallopeptidases exhibit unique specificity for the substrates and peptide bonds they cleave. Development of countermeasures and therapeutics for BoNTs is a priority because of their extreme toxicity and potential misuse as biowarfare agents. Though they share sequence homology and structural similarity, the structural information on each one of them is required to understand the mechanism of action of all of them because of their specificity. Unraveling the mechanism will help in the ultimate goal of developing inhibitors as antibotulinum drugs for the toxins. Here, we report the high-resolution structure of active BoNT/F catalytic domain in two crystal forms. The structure was exploited for modeling the substrate binding and identifying the S1' subsite and the putative exosites which are different from BoNT/A or BoNT/B. The orientation of docking of the substrate at the active site is consistent with the experimental BoNT/A-LC:SNAP-25 peptide model and our proposed model for BoNT/E-LC:SNAP-25.

About this Structure

2A97 is a Single protein structure of sequence from Clostridium botulinum. Full crystallographic information is available from OCA.

Reference

Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design., Agarwal R, Binz T, Swaminathan S, Biochemistry. 2005 Sep 6;44(35):11758-65. PMID:16128577

Page seeded by OCA on Thu Mar 20 15:46:58 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools